A Clinical Trial of Chidamide Combined With Etoposide in Relapsed or Refractory NK/T-cell Lymphoma

NCT04490590 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

NK/T-Cell Lymphoma

Interventions

DRUG: Chidamide+ Etoposide

Sponsor

Mingzhi Zhang